Jia-Lin Yang
Surgical Oncology Research Group
Oncology Research Centre
Prince of Wales Clinical School
University of New South Wales
Australia
Name/email consistency: high
- Selective sensitivity to carboxyamidotriazole by human tumor cell lines with DNA mismatch repair deficiency. Yang, J.L., Qu, X.J., Yu, Y., Kohn, E.C., Friedlander, M.L. Int. J. Cancer (2008)
- Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha. Yang, J.L., Qu, X.J., Hayes, V.M., Brenner, P.C., Russell, P.J., Goldstein, D. BJU Int. (2007)
- Expression of HER1/EGFR protein in human soft tissue sarcomas. Yang, J.L., Hannan, M.T., Russell, P.J., Crowe, P.J. Eur. J. Surg. Oncol (2006)
- Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines. Yang, J.L., Qu, X.J., Russell, P.J., Goldstein, D. Cancer Lett. (2005)
- Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. Yang, J.L., Qu, X.J., Russell, P.J., Goldstein, D. Oncology (2005)
- Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer. Yang, J.L., Jackson, P., Yu, Y., Russell, P.J., Markovic, B., Crowe, P.J. Anticancer Res. (2002)
- Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. Yang, J.L., Seetoo, D., Wang, Y., Ranson, M., Berney, C.R., Ham, J.M., Russell, P.J., Crowe, P.J. Int. J. Cancer (2000)